Identification of RNPC3 as a Novel JAK2 Fusion Partner Gene in B‐acute Lymphoblastic Leukemia Refractory to Combination Therapy Including Ruxolitinib

Molecular genetics & genomic medicine - United States
doi 10.1002/mgg3.1110
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2017English

PAX5-KIAA1549L: A Novel Fusion Gene in a Case of Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia

Molecular Cytogenetics
BiochemistryMolecular MedicineGeneticsMolecular Biology
2015English

CTL019 (Tisagenlecleucel): CAR-T Therapy for Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

H2AFY Is a Novel Fusion Partner of MECOM in Acute Myeloid Leukemia

Cancer genetics
Cancer ResearchGeneticsMolecular Biology
2018English

a Novel AGGF1-PDGFRb Fusion in Pediatric T-Cell Acute Lymphoblastic Leukemia

Haematologica
Hematology
2017English

Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia

Cancer immunology research
Cancer ResearchImmunology
2019English

Targeting the Thioredoxin System as a Novel Strategy Against B Cell Acute Lymphoblastic Leukemia

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Meta-Analysis of Gene Expression in Relapsed Childhood B-Acute Lymphoblastic Leukemia

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Role of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia

Memo - Magazine of European Medical Oncology
OncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy